Skip to content

Effects of a Brief Meditation Training on Negative Affect, Trait Anxiety and Concentrated Attention

Carolina Baptista Menezes, Lisiane Bizarro

Paidéia December 1, 2015 DOI: 10.1590/1982-43272562201513 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled pilot study Peer reviewed
Sample size 33
Population Nonclinical adults (experimental group: 14, 51.8% female, mean age 23.9; control group: 19, 62% female, mean age 24.9)
Intervention Focused meditation
Duration Five days
Measures Positive Affect and Negative Affect Scale, State and Trait Anxiety Inventory, Concentrated Attention Test
Topics Anxiety Meditation
Key points Five days of focused meditation reduced negative affect and trait anxiety and improved correct responses on the attention test relative to controls, suggesting short meditation training may benefit some psychological variables.

Abstract

AbstractMeditation has been associated with positive psychological outcomes, but few studies have investigated brief interventions. This randomized controlled pilot study assessed the effects of five days of focused meditation on positive and negative affect, state and trait anxiety, as well as concentrated attention in a nonclinical sample distributed in two groups (experimental = 14, 51.8% female, Mage= 23.9; control = 19, 62% female, Mage= 24.9). The instruments used were the Positive Affect and Negative Affect Scale, State and Trait Anxiety Inventory, and the Concentrated Attention Test. The meditation group reduced negative affect and trait anxiety, and also improved correct responses on the attention test, relative to controls. These preliminary findings indicate that even short focused meditation training may help improve some psychological variables. It is discussed that the early manifestation of these benefits may be especially relevant to strengthen the motivation to continue and practice regularly.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Cited by 6

and 1 more in the library

Cites 16

and 11 more in the library

Explore topics